Pilot Study to prove the reproducibility of the intestinal environment of PMAS System through the production of Equol after intake of Soy Isoflavone
Not Applicable
Completed
- Conditions
- Not Applicable
- Registration Number
- KCT0008816
- Lead Sponsor
- HEM Pharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
1. Healthy adults who are 19 years of age or older.
2. Individuals who have willingly and voluntarily agreed to participate in this study.
Exclusion Criteria
1. Individuals who have a hypersensitivity or allergy to soy materials, such as soy isoflavones.
2. Individuals who have been determined by the tester to be unsuitable for participation in the human application test.
3. Individuals who have used systemic antibiotics within one week prior to Visit 1.
4. Pregnant and lactating women.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The conformity between equol generators and non-generators was confirmed based on the results obtained from both human application tests and PMAS (Pharmaceutical Meta-Analytical Screening).
- Secondary Outcome Measures
Name Time Method It can be confirmed through medical examination, physical examination, and adverse reaction evaluation conducted at the time of visit.